0001493152-23-016244.txt : 20230511 0001493152-23-016244.hdr.sgml : 20230511 20230511060529 ACCESSION NUMBER: 0001493152-23-016244 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20230509 ITEM INFORMATION: Material Modifications to Rights of Security Holders ITEM INFORMATION: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230511 DATE AS OF CHANGE: 20230511 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LadRx Corp CENTRAL INDEX KEY: 0000799698 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 581642750 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-15327 FILM NUMBER: 23908649 BUSINESS ADDRESS: STREET 1: 11726 SAN VICENTE BOULEVARD STREET 2: SUITE 650 CITY: LOS ANGELES STATE: CA ZIP: 90049 BUSINESS PHONE: 310-826-5648 MAIL ADDRESS: STREET 1: 11726 SAN VICENTE BOULEVARD STREET 2: SUITE 650 CITY: LOS ANGELES STATE: CA ZIP: 90049 FORMER COMPANY: FORMER CONFORMED NAME: CYTRX CORP DATE OF NAME CHANGE: 19920703 8-K 1 form8-k.htm
0000799698 false --12-31 0000799698 2023-05-09 2023-05-09 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): May 9, 2023

 

 

 

LADRX CORPORATION

(Exact name of registrant as specified in its charter)

 

Delaware   000-15327   58-1642740

(State or other jurisdiction

of incorporation)

  

(Commission

File Number)

  

(IRS Employer

Identification No.)

 

11726 San Vicente Boulevard, Suite 650

Los Angeles, California 90049

(Address of principal executive offices) (Zip Code)

 

(310) 826-5648

Registrant’s telephone number, including area code

 

 

Former name or former address, if changed since last report

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(g) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.001 per share Series B Junior Participating Preferred Stock Purchase Rights   LADX   OTC Markets

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 3.03. Material Modification to Rights of Security Holders.

 

To the extent required by Item 3.03 of Form 8-K, the information contained in Item 5.03 of this report is incorporated herein by reference.

 

Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

 

On May 9, 2023, LadRx Corporation (the “Company”) filed a Certificate of Amendment of Restated Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of State of Delaware to effect a 1-for-100 reverse stock split of the shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), either issued and outstanding or held by the Company as treasury stock, effective as of 5:00 a.m. (Pacific time) on May 17, 2023 (the “Reverse Stock Split”). As previously reported, the Company held its 2022 annual meeting of stockholders (the “Annual Meeting”) on July 27, 2022, at which meeting the Company’s stockholders approved the amendment to the Company’s Restated Certificate of Incorporation (the “Certificate of Incorporation”) to effect a reverse stock split of the Common Stock at a ratio in the range of 1-for-2 to 1-for-100, with such ratio to be determined by the Company’s Board of Directors (the “Board”) and included in a public announcement. On May 9, 2023, the Board determined to effect the Reverse Stock Split at a ratio of 1-for-100 and approved the corresponding final form of the Certificate of Amendment.

 

As a result of the Reverse Stock Split, every 100 shares of issued and outstanding Common Stock will be automatically combined into one issued and outstanding share of Common Stock, without any change in the par value per share. No fractional shares will be issued as a result of the Reverse Stock Split. Any fractional shares that would otherwise have resulted from the Reverse Stock Split will be rounded up to the next whole number. The Reverse Stock Split will reduce the number of shares of Common Stock outstanding from 46,587,391 shares to approximately 465,587 shares, subject to adjustment for the rounding up of fractional shares. The number of authorized shares of Common Stock under the Certificate of Incorporation will remain unchanged at 62,393,940 shares.

 

Proportionate adjustments will be made to the per share exercise price and the number of shares of Common Stock that may be purchased upon exercise of outstanding stock options granted by the Company. The number of shares reserved for issuance under the Company’s 2019 Stock Incentive Plan will be proportionately reduced in accordance with the terms of such plan.

 

The Common Stock will begin trading on a reverse stock split-adjusted basis on The OTC Markets on May 17, 2023. The trading symbol for the Common Stock will remain “LADX.” The new CUSIP number for the Common Stock following the Reverse Stock Split is 232828608. On March 15, 2023, the Company announced that it was undergoing a review of strategic alternatives that could include a strategic sale, a merger or reverse merger, implementing a reverse stock split for the purposes of up-listing to the Nasdaq Capital Market (“Nasdaq”), seeking additional financing or some combination of the aforementioned scenarios. The Company believes that effecting the Reverse Stock Split at this time, given the low trading price of the Company’s Common Stock, would best position the Company in pursuing any alternatives that result from the strategic review. The Company believes that having a consistently low share price makes the Company less attractive to potential strategic partners and renders it impossible to consider an up-listing to Nasdaq.

 

For more information about the Reverse Stock Split, see the Company’s definitive proxy statement filed with the U.S. Securities and Exchange Commission on June 16, 2022, the relevant portions of which are incorporated herein by reference. The information set forth herein is qualified in its entirety by reference to the complete text of the Certificate of Amendment, a copy of which is filed with this Current Report on Form 8-K as Exhibit 3.1.

 

Item 7.01. Regulation FD Disclosure.

 

On May 10, 2023, the Company issued a press release announcing the Reverse Stock Split. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The Company undertakes no obligation to update, supplement or amend the materials attached hereto as Exhibit 99.1.

 

In accordance with General Instruction B.2 of Form 8-K, the information in this Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended, except as shall be expressly set forth by reference in such a filing. Furthermore, the furnishing of information under Item 7.01 of this Current Report on Form 8-K is not intended to constitute a determination by the Company that the information contained herein, including the exhibits hereto, is material or that the dissemination of such information is required by Regulation FD.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit Number   Description
3.1   Certificate of Amendment of Restated Certificate of Incorporation of LadRx Corporation
99.1   Press Release, issued May 10, 2023 (furnished pursuant to Item 7.01)
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  LADRX CORPORATION
   
Date: May 11, 2023 /s/ John Y. Caloz
  John Y. Caloz
  Chief Financial Officer

 

 

 EX-3.1 2 ex3-1.htm

 

Exhibit 3.1

 

Certificate of Amendment

of

Restated Certificate of Incorporation

of

LADRX Corporation

 

LadRx Corporation (the “Corporation”), a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware, does hereby certify that:

 

  1. The original Certificate of Incorporation of this Corporation was filed with the Secretary of State of Delaware on February 28, 1985.
     
  2. The Restated Certificate of Incorporation of this Corporation was filed with the Secretary of State of Delaware on November 15, 2007 (the “Certificate of Incorporation”).
     
  3. The Certificate of Incorporation was further amended by Certificates of Amendment of Restated Certificate of Incorporation of LadRx Corporation, filed with the Secretary of State of Delaware on July 2, 2008, July 8, 2011, May 15, 2012, October 31, 2017, March 16, 2022 and September 19, 2022.
     
  4. Resolutions were duly adopted by the Board of Directors of the Corporation setting forth this proposed Amendment to the Certificate of Incorporation and declaring said amendment to be advisable and calling for the consideration and approval thereof at a meeting of the stockholders of the Corporation.
     
  5. Resolutions were duly adopted by the Board of Directors of the Corporation, in accordance with the provisions of the Certificate of Incorporation set forth below, providing that, effective as of 5:00 a.m., Pacific time, on May 17, 2023, each one hundred (100) issued and outstanding shares of the Corporation’s Common Stock, par value $0.001 per share, shall be converted into one (1) share of the Corporation’s Common Stock, par value $0.001 per share, as constituted following such date.
     
  6. The Certificate of Incorporation is hereby amended by revising Article FOURTH to include a new paragraph as follows:

 

“Upon the effectiveness of the filing of this Certificate of Amendment (the “Effective Time”) each share of the Corporation’s common stock, $0.001 par value per share (the “Old Common Stock”), either issued or outstanding or held by the Corporation as treasury stock, immediately prior to the Effective Time, will be automatically reclassified and combined (without any further act) into a smaller number of shares such that each one hundred (100) shares of Old Common Stock issued and outstanding or held by the Company as treasury stock immediately prior to the Effective Time is reclassified into one share of Common Stock, $0.001 par value per share, of the Corporation (the “New Common Stock”), the exact ratio within such range to be determined by the board of directors of the Corporation prior to the Effective Time and publicly announced by the Corporation (the “Reverse Stock Split”). The Board of Directors shall make provision for the issuance of that number of fractions of New Common Stock such that any fractional share of a holder otherwise resulting from the Reverse Stock Split shall be rounded up to the next whole number of shares of New Common Stock. Any stock certificate that, immediately prior to the Effective Time, represented shares of the Old Common Stock will, from and after the Effective Time, automatically and without the necessity of presenting the same for exchange, represent the number of shares of the New Common Stock into which such shares of Old Common Stock shall have been reclassified plus the fraction, if any, of a share of New Common Stock issued as aforesaid.”

 

  7. Pursuant to the resolution of the Board of Directors, a meeting of the stockholders of the Company was duly called and held upon notice in accordance with Section 222 of the General Corporation Law of the State of Delaware at which meeting the necessary number of shares as required by statute were voted in favor of the foregoing amendment.
     
  8. The foregoing amendment was duly adopted in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware.

 

[Signature page follows.]

 

 

 

 

[SIGNATURE PAGE TO CERTIFICATE OF AMENDMENT]

 

IN WITNESS WHEREOF, LadRx Corporation has caused this Certificate to be duly executed by the undersigned duly authorized officer as of this 9th day of May, 2023.

 

  LADRX Corporation
     
  By: /s/ John Y. Caloz
  Name: John Y. Caloz
  Title: Chief Financial Officer

 

 

 EX-99.1 3 ex99-1.htm

 

Exhibit 99.1

 

LadRx Announces Reverse Stock Split

 

LOS ANGELES—(BUSINESS WIRE)—LadRx Corporation (OTCQB: LADX) (“LadRx” or the “Company”), a biopharmaceutical innovator focused on research and development of life-saving cancer therapeutics, today announced that it intends to effect a reverse stock split of its common stock at a ratio of 1 post-split share for every 100 pre-split shares. The reverse stock split will become effective at 5:00 a.m. PDT on Wednesday, May 17, 2023. The Company’s common stock will continue to be traded on the OTC Capital Markets under the symbol “LADX” and will begin trading on a split-adjusted basis when the market opens on Thursday, May 18, 2023. The new CUSIP number for the common stock following the reverse stock split is 232828707.

 

At the Annual Meeting of Stockholders held on July 27, 2022, the Company’s stockholders granted the Company’s Board of Directors (the “Board”) the discretion to effect a reverse stock split of the Company’s common stock through the amendment to its Amended and Restated Certificate of Incorporation at a ratio in the range of 1-for-2 to 1-for-100, with such ratio to be determined by the Board and included in a public announcement. On March 15, 2023, the Company announced that it was undergoing a review of strategic alternatives that could include a strategic sale, a merger or reverse merger, implementing a reverse stock split for the purposes of up-listing to NASDAQ, seeking additional financing or some combination of the aforementioned scenarios. The Company believes that effecting the reverse split at this time, given the low trading price of the Company’s common stock, would best position the Company in pursuing any alternatives that result from the strategic review. The Company believes that having a consistently low share price makes the Company less attractive to potential strategic partners and renders it impossible to consider an up-listing to Nasdaq. At the effective time of the reverse stock split, every 100 shares of the Company’s issued and outstanding common stock will be converted automatically into one issued and outstanding share of common stock without any change in the par value per share. Stockholders holding shares through a brokerage account will have their shares automatically adjusted to reflect the 1-for-100 reverse stock split. It is not necessary for stockholders holding shares of the Company’s common stock in certificated form to exchange their existing stock certificates for new stock certificates of the Company in connection with the reverse stock split, although stockholders may do so if they wish.

 

The reverse stock split will affect all stockholders uniformly and will not alter any stockholder’s percentage interest in the Company’s equity, except to the extent that the reverse stock split would result in a stockholder owning a fractional share. Any fractional share of a stockholder resulting from the reverse stock split will be rounded up to the nearest whole number of shares. The reverse stock split will reduce the number of shares of the Company’s common stock outstanding from 48,190,080 shares to approximately 481,901 shares. Proportional adjustments will be made to the number of shares of the Company’s common stock issuable upon exercise or conversion of the Company’s equity awards, warrants and other convertible securities, as well as the applicable exercise or conversion price thereof. Stockholders with shares in brokerage accounts should direct any questions concerning the reverse stock split to their broker; all other stockholders may direct questions to the Company’s transfer agent, AST, at (718) 921-8300, ext 6462.

 

 

 

 

Forward-Looking Statements

 

This press release may contain certain statements relating to future results which are forward-looking statements, including whether the company’s strategic review will be successful and whether the stock split will be help the company be more successful in evaluating strategic alternatives. These statements are not historical facts, but instead represent only LadRx’s belief regarding future events, many of which, by their nature, are inherently uncertain and outside of LadRx’s control. Such statements involve risks and uncertainties that could cause actual events or results to differ materially from the events or results described in the forward-looking statements; and other risks and uncertainties described in the most recent annual and quarterly reports filed by LadRx with the SEC, including disclosures under the heading “Risk Factors”, and current reports filed since the date of the LadRx’s most recent annual report. All forward-looking statements are based upon information available to LadRx on the date the statements are first published. LadRx undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

 

About LadRx

 

LadRx Corporation (OTCQB: LADX) is a biopharmaceutical company with expertise in discovering and developing new therapeutics principally to treat patients with cancer. LadRx’s most recent advanced drug conjugate, aldoxorubicin, is an improved version of the widely used anti-cancer drug doxorubicin and has been out-licensed to ImmunityBio, Inc. In addition, LadRx’s drug candidate, arimoclomol, was sold to Orphazyme A/S (now Zevra Therapeutics) in exchange for milestone payments and royalties. Zevra is developing arimoclomol and is currently focused on Niemann-Pick disease Type C (NPC). LadRx Corporation’s website is www.ladrxcorp.com.

 

Contacts

 

Longacre Square Partners

Greg Marose / Charlotte Kiaie

ladrx@longacresquare.com

 

 

 EX-101.SCH 4 ladx-20230509.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 5 ladx-20230509_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 6 ladx-20230509_pre.xml XBRL PRESENTATION FILE XML 7 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Cover
May 09, 2023
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date May 09, 2023
Current Fiscal Year End Date --12-31
Entity File Number 000-15327
Entity Registrant Name LADRX CORPORATION
Entity Central Index Key 0000799698
Entity Tax Identification Number 58-1642740
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 11726 San Vicente Boulevard
Entity Address, Address Line Two Suite 650
Entity Address, City or Town Los Angeles
Entity Address, State or Province CA
Entity Address, Postal Zip Code 90049
City Area Code (310)
Local Phone Number 826-5648
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.001 per share Series B Junior Participating Preferred Stock Purchase Rights
Trading Symbol LADX
Entity Emerging Growth Company false
XML 8 form8-k_htm.xml IDEA: XBRL DOCUMENT 0000799698 2023-05-09 2023-05-09 iso4217:USD shares iso4217:USD shares 0000799698 false --12-31 8-K 2023-05-09 LADRX CORPORATION DE 000-15327 58-1642740 11726 San Vicente Boulevard Suite 650 Los Angeles CA 90049 (310) 826-5648 false false false false Common Stock, par value $0.001 per share Series B Junior Participating Preferred Stock Purchase Rights LADX false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 1 23 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://ladrxcorp.com/role/Cover Cover Cover 1 false false All Reports Book All Reports form8-k.htm ex3-1.htm ex99-1.htm ladx-20230509.xsd ladx-20230509_lab.xml ladx-20230509_pre.xml http://xbrl.sec.gov/dei/2022 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "form8-k.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 23 }, "contextCount": 1, "dts": { "inline": { "local": [ "form8-k.htm" ] }, "labelLink": { "local": [ "ladx-20230509_lab.xml" ] }, "presentationLink": { "local": [ "ladx-20230509_pre.xml" ] }, "schema": { "local": [ "ladx-20230509.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 59, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 3, "total": 3 }, "keyCustom": 0, "keyStandard": 23, "memberCustom": 0, "memberStandard": 0, "nsprefix": "LADX", "nsuri": "http://ladrxcorp.com/20230509", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form8-k.htm", "contextRef": "From2023-05-09to2023-05-09", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://ladrxcorp.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form8-k.htm", "contextRef": "From2023-05-09to2023-05-09", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ladrxcorp.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ladrxcorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ladrxcorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ladrxcorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ladrxcorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ladrxcorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ladrxcorp.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ladrxcorp.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r11", "r13", "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ladrxcorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ladrxcorp.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ladrxcorp.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ladrxcorp.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ladrxcorp.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ladrxcorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ladrxcorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ladrxcorp.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ladrxcorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ladrxcorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ladrxcorp.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ladrxcorp.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ladrxcorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ladrxcorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ladrxcorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ladrxcorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ladrxcorp.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ladrxcorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ladrxcorp.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ladrxcorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ladrxcorp.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ladrxcorp.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ladrxcorp.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ladrxcorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ladrxcorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ladrxcorp.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ladrxcorp.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ladrxcorp.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ladrxcorp.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ladrxcorp.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ladrxcorp.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ladrxcorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ladrxcorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ladrxcorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ladrxcorp.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ladrxcorp.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ladrxcorp.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ladrxcorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ladrxcorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ladrxcorp.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ladrxcorp.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ladrxcorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ladrxcorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ladrxcorp.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ladrxcorp.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ladrxcorp.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ladrxcorp.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ladrxcorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ladrxcorp.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ladrxcorp.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r10": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r11": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r12": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r13": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r14": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r15": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r16": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r17": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r18": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r19": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r9": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 15 0001493152-23-016244-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-23-016244-xbrl.zip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